Mr. Sivikofsky has over 20 years’ industry experience in the biotech industry, financial services and accounting both in Australia and Europe. Mr. Sivikofsky is a seasoned finance executive, having been the Chief Financial Officer at Luoda Pharma and Bova UK, private biotech companies based in London, and Investor First Limited (now HUB24 Limited), an ASX-listed financial services company (ASX:INQ (now HUB).
Further, Mr. Sivikofsky previously served as a Director of Financial Advisory Services at Deloitte Australia, where he specialized in Chief Financial Officer secondments and technical accounting advisory engagements. Prior to that role, Mr. Sivikofsky was a financial controller at Babcock & Brown in both Sydney and London. Mr. Sivikofsky is a Chartered Accountant (FCA) and a graduate member of the Australian Institute of Company Directors (GAICD).
Mr. Sivikofsky has a Bachelor of Commerce degree from the University of Wollongong (majoring in Finance & Accounting) and a Graduate Diploma in Applied Finance & Investment from FINSIA.